Clinical Profile of PiB-Positive Corticobasal Syndrome

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Burrell, James R ^a,b,c   Hornberger, Michael ^a,c   Villemagne, Victor L ^d,e   Rowe, Christopher C ^e   Hodges, John R ^a,c  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d AUSTIN HEALTH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PITTSBURGH COMPOUND B;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEPTH PERCEPTION; DISEASE DURATION; EDUCATION; FEMALE; GENDER; HUMAN; INSULA; MALE; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; SUPERIOR TEMPORAL GYRUS; VOXEL BASED MORPHOMETRY;

AGED; ALZHEIMER DISEASE; ANILINE COMPOUNDS; CARBON RADIOISOTOPES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEURODEGENERATIVE DISEASES; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; THIAZOLES;

EID: 84875939750     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061025     Document Type: Article

References (37)

1. Rinne JO, Lee MS, Thompson PD, Marsden CD, (1994) Corticobasal degeneration: A clinical study of 36 cases. Brain 117: 1183-1196 doi:10.1093/brain/117.5.1183.
2. Kertesz A, McMonagle P, (2010) Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci 289: 138-143 doi:10.1016/j.jns.2009.08.036.
3. Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH, (2009) Is the pathology of corticobasal syndrome predictable in life? Mov Disord 24: 1593-1599 doi:10.1002/mds.22558.
4. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG, (2000) The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55: 1368-1375.
5. Soliveri P, Piacentini S, Girotti F, (2005) Limb apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 64: 448-453 doi:10.1212/01.WNL.0000150732.92567.BA.
6. Mathew R, Bak TH, Hodges JR, (2011) Screening for cognitive dysfunction in corticobasal syndrome: utility of Addenbrooke's cognitive examination. Dement Geriatr Cogn Disord 31: 254-258 doi:10.1159/000327169.
7. Graham NL, Bak T, Patterson K, Hodges JR, (2003) Language function and dysfunction in corticobasal degeneration. Neurology 61: 493-499.
8. Graham NL, Bak TH, Hodges JR, (2003) Corticobasal degeneration as a cognitive disorder. Mov Disord 18: 1224-1232 doi:10.1002/mds.10536.
9. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, et al. (1999) Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 53: 795-800.
10. Whitwell JL, Jack CR, Boeve BF, Parisi JE, Ahlskog JE, et al. (2010) Imaging correlates of pathology in corticobasal syndrome. Neurology 75: 1879-1887 doi:10.1212/WNL.0b013e3181feb2e8.
11. Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, et al. (2011) Clinicopathological correlations in corticobasal degeneration. Ann Neurol 70: 327-340 doi:10.1002/ana.22424.
12. Ling H, O'Sullivan SS, Holton JL, Revesz T, Massey LA, et al. (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133: 2045-2057 doi:10.1093/brain/awq123.
13. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, et al. (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55: 306-319 doi:10.1002/ana.20009.
14. Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, et al. (2007) Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol 64: 431-434 doi:10.1001/archneur.64.3.431.
15. Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, et al. (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 131: 1630-1645 doi:10.1093/brain/awn016.
16. Mathew R, Bak TH, Hodges JR, (2012) Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatr 83: 405-410.
17. Leyton CE, Villemagne VL, Savage S, Pike KE, Ballard KJ, et al. (2011) Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging. Brain 134: 3030-3043 doi:10.1093/brain/awr216.
18. Wedderburn C, Wear H, Brown J, Mason SJ, Barker RA, et al. (2008) The utility of the Cambridge Behavioural Inventory in neurodegenerative disease. J Neurol Neurosurg Psychiatr 79: 500-503 doi:10.1136/jnnp.2007.122028.
19. Bozeat S, Gregory CA, Ralph MA, Hodges JR, (2000) Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatr 69: 178-186.
20. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR, (2006) The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21: 1078-1085 doi:10.1002/gps.1610.
21. Folstein MF, Folstein SE, McHugh PR, (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
22. Warrington E, James M (1991) The visual object and space perception battery. Bury St Edmunds: Thames Valley Test Company.
23. Rey A, (1941) L'examen psychologique dans les cas d'encéphalopathie traumatique.(Les problems.). Archives de psychologie 28: 286-340.
24. Baddeley AD (1994) Doors and people: A test of visual and verbal recall and recognition. Thames Valley Test Company.
25. Hodges JR (2007) Cognitive Assessment for Clinicians. 2nd ed. Oxford University Press, USA.
26. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, et al. (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31: 1275-1283 doi:10.1016/j.neurobiolaging.2010.04.007.
27. Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, et al. (2011) Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol 69: 181-192 doi:10.1002/ana.22248.
28. Hu W, Rippon G, Boeve BF, Knopman DS, Petersen RC, et al. (2009) Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 24: 1375-1379 doi:10.1002/mds.22574.
29. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, et al. (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55: 335-346 doi:10.1002/ana.10825.
30. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, et al. (2011) Classification of primary progressive aphasia and its variants. Neurology 76: 1006-1014 doi:10.1212/WNL.0b013e31821103e6.
31. Mesulam M, Wicklund A, Johnson N, Rogalski E, Léger GC, et al. (2008) Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 63: 709-719 doi:10.1002/ana.21388.
32. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, et al. (2008) Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64: 388-401 doi:10.1002/ana.21451.
33. Gorno-Tempini ML, Brambati SM, Ginex V, Ogar J, Dronkers NF, et al. (2008) The logopenic/phonological variant of primary progressive aphasia. Neurology 71: 1227-1234 doi:10.1212/01.wnl.0000320506.79811.da.
34. Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, et al. (2006) Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 63: 81-86 doi:10.1001/archneur.63.1.81.
35. Josephs KA, Whitwell JL, Boeve BF, Knopman DS, Petersen RC, et al. (2010) Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease. Mov Disord 25: 1246-1252 doi:10.1002/mds.23062.
36. Rogalski E, Cobia D, Harrison TM, Wieneke C, Thompson CK, et al. (2011) Anatomy of language impairments in primary progressive aphasia. J Neurosci 31: 3344-3350 doi:10.1523/JNEUROSCI.5544-10.2011.
37. Whitwell JL, Jack CR Jr, Przybelski SA, Parisi JE, Senjem ML, et al. (2011) Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging 32: 1531-1541 doi:10.1016/j.neurobiolaging.2009.10.012.